Sign In
Buy ACHV
$4.92
-0.110 (-2.19%)
At Close: Jun 03, 2026
Subjects treated with cytisinicline were 55% more likely to quit smoking at 6 months and experienced significantly fewer side effects compared to those who received varenicline SEATTLE, WA and VANCOUV
Achieve Life Sciences to Participate in M-Vest and Maxim Group Inaugural Emerging Growth Virtual Conference
05:30am, Tuesday, 16'th Mar 2021
Presenting Innovative Small and Mid-Cap Companies in Healthcare, Industrials, Electric Vehicles, TMT, and Consumer Products SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / March 16, 2021 / Achieve Life S
Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of Directors
06:30am, Monday, 15'th Mar 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / March 15, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercializat
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2020 Results - Earnings Call Transcript
10:18pm, Thursday, 11'th Mar 2021
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2020 Results - Earnings Call Transcript
Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate Update
04:05pm, Thursday, 11'th Mar 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / March 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercializati
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercializatio
SEATTLE and VANCOUVER, B.C., Dec. 7, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization
Achieve Life Sciences Announces Pricing of $15 Million Public Offering
08:00am, Thursday, 03'rd Dec 2020
SEATTLE and VANCOUVER, B.C., Dec. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q3 2020 Results - Earnings Call Transcript
09:41am, Friday, 13'th Nov 2020
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q3 2020 Results - Earnings Call Transcript
Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
05:30am, Thursday, 29'th Oct 2020
SEATTLE and VANCOUVER, BC, Oct. 29, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization o
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
05:30am, Tuesday, 27'th Oct 2020
SEATTLE and VANCOUVER, BC, Oct. 27, 2020 /PRNewswire/ --Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of
Pharma Companies Have Improved How They Engage with Healthcare Providers During COVID-19, Finds New Research from Accenture
12:00am, Monday, 10'th Aug 2020
Pharma companies have improved how they engage with healthcare providers during COVID-19, says Accenture.
Brenntag AG (BNTGF) CEO Christian Kohlpaintne on Q2 2020 Results - Earnings Call Transcript
06:44pm, Sunday, 09'th Aug 2020
Brenntag AG. (OTCPK:BNTGF) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Christian Kohlpaintne - Chief Executive Officer Georg Müller - Chief Financial Officer Co
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2020 Results - Earnings Call Transcript
11:24am, Sunday, 09'th Aug 2020
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Exe
HighRadius Adds New Leader to Drive Finance Digital Transformation in Growing Enterprise Client Base
12:00am, Friday, 07'th Aug 2020
HighRadius, a fintech enterprise Software-as-a-Service (SaaS) company specializing in automating the order-to-cash and treasury management processes,
